Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPIRE 1: Ciprofloxacin DPI for Non-Cystic Fibrosis Bronchiectasis
NCT01764841Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of ciprofloxacin in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Bayer. Started May 2013; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT01764841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764841.